New Toxicity Grading Criteria Help Standardize Management of CAR T-Cell Therapy-Related AEs
Newly standardized grading criteria will help to regulate the management of CAR T-cell therapy¬–related toxicities, like cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).
Noninvasive Stool Test Effectively Detects Colon Cancer
The iFOBT test examines the stool for hidden blood, which could come from anywhere in the GI tract, and possibly indicates a colon tumor or precancerous growths known as polyps.
ASCO 2011: What Nurses Need to Know
Personal perspectives from oncology nurses of abstracts presented at ASCO on research with the potential to change practice, important studies that failed to meet expectations, and topics particularly relevant to oncology nurses.
Advocacy Spotlight: Cancer and Careers
Cancer and Careers is the only program of its kind, dedicated to empowering and educating people with cancer to thrive in their workplace.
Spotlight on Oral Oncolytics
Oral oncolytic treatment, a self-administered medication, empowers patients with a level of control over their cancer treatment experience.
Interview Series: Carlton Brown, PhD, RN ONS President
Carlton Brown, PhD, RN, has been a member of ONS for 18 years and is in the second year of his 2-year term as president.
Donna Berry, PhD, RN 2011 ONS Distinguished Researcher Award Winner
Nurse scientist Donna Berry, PhD, RN, received the 2011 ONS Distinguished Researcher Award, which recognizes a nurse researcher whose work has enhanced the science and practice of oncology nursing.
Nurses Go Nuclear
Singer, songwriter, and cancer survivor Charlie Lustman brought his Made Me Nuclear album and Musical HOPE Campaign to the ONS 36th Annual Congress.
OncLive Nursing FDA Updates From April 2011
3D mammogram system approved, NCCN 2011 Avastin breast cancer guidelines, and the approval of generic docetaxel.
Lung Cancer Stigma, Smoking Status, Depression and Quality of Life
Negative attitudes toward smokers extend to patients with lung cancer, regardless of whether or not they have ever actually smoked
Nurse's Insight: An Interview With JTCC Advanced Practice Nurse Laura Metcalfe
As part of the Intellisphere Oncology Specialty Group's new partnership with the John Theurer Cancer Center (JTCC), our online and print coverage will provide special insight from JTCC's oncology healthcare professionals
Immune Engager Therapies Improve Responses, PFS in RRMM After CAR T-Cell Therapy
Liso-Cel Elicits Rapid, Durable Responses in Relapsed/Refractory CLL/SLL
Adding Azoles May Not Impact Efficacy of Ruxolitinib in Acute GVHD Treatment
Ruxolitinib Plus Belumosudil Confers a 55% Response Rate in GVHD
2 Commerce Drive Cranbury, NJ 08512